Objective-To determine the relations of plasma fibrinogen to family history of premature heart disease, personal history of hypertension, diabetes, stroke, coronary heart disease, and to presence of intermittent claudication.
(SE = 0.01) gIl, n = 3367; women 2-34 (0-01) gil, n = 3096), predefined cases of either myocardial infarction (men: (0.02) gil, n = 248; women: 2-63 (0.04) gil, n = 72) or angina (men: 2 45 (0.02) gil, n = 394; women: 2 50 (0 02) gil, n = 398) had significantly higher plasma fibrinogen concentrations (p < 0-001). After adjustment for 10 other coronary risk factors, there was a noticeable linear trend in the odds ratios for myocardial infarction across all quartiles (quarters) of plasma fibrinogen concentrations in both sexes. Similarly, the risk of angina increased linearly with increasing fibrinogen concentrations, although the test for a linear trend was NS among women.
Conclusions-This large population study confirms that plasma fibrinogen is not only a risk factor for coronary heart disease and stroke, but it is also raised with family history of premature heart disease and with personal history of hypertension, diabetes, and intermittent claudication. presence of (Br Heart j 1993;69: [338] [339] [340] [341] [342] Recently, reports from the follow up of five epidemiological studies have related plasma fibrinogen to the incidence of coronary heart disease.'-5 Only two of these, however, the Caerphilly and Speedwell collaborative studies6 and the Northwick Park Heart Study8 have reported the correlation of baseline plasma fibrinogen concentration with prevalent coronary disease. Furthermore, no random population study has related plasma fibrinogen concentrations to family history of premature heart disease, personal history of hypertension, diabetes, or stroke, although cross sectional studies have consistently related plasma fibrinogen to peripheral vascular disease.9 10 In the Scottish Heart Health Study,' 12 plasma fibrinogen was measured in 8824 middle aged men and women. A previous report has examined the relations of plasma fibrinogen to coronary risk factors in this population.'3 With so many participants the strength and consistency of any relations reported in previous smaller studies can be tested. Also, as we have data on both sexes, any sex differences in the association between fibrinogen and prevalent disease can be explored. Our paper reports the relations of plasma fibrinogen with family history of heart disease and with personal history of hypertension, diabetes, stroke, peripheral vascular disease (as indicated by intermittent claudication), and with prevalent coronary heart disease. *p < 0 05; ***p < 0-001 for history v no history (t tests).
Patients and methods
previously been shown to affect fibrinogen concentrations in this population.'3 Finally, the sex effect was investigated further as both a main effect and also for its interaction with plasma fibrinogen.
Results Table 1 shows that subjects with either a parental or a sibling history of premature heart disease had significantly higher fibrinogen concentrations than those without (after standardisation for age and smoking). Subjects with a self reported medical history of high blood pressure, diabetes, or stroke, and those with intermittent claudication had higher mean plasma fibrinogen concentrations than subjects with no disease, after standardisation for age, body mass index, and smoking (table 2) . Some of these associations were statistically significant in men only.
MYOCARDIAL INFARCTION
Compared with those participants without cardiovascular or related disease, men and women with any of the three indicators of myocardial infarction (medical history, chest pain on the Rose questionnaire, and electrocardiogram) all had significantly higher plasma fibrinogen concentrations than those without (table 3) . When the interrelations of the three indicators were examined, those subjects without cardiovascular or related disease (p < 0-001). For women, the figures ith two or more indicators of dis-were 2-63 (0-04) g/l, (n = 72) and 2134 (0-01) igher fibrinogen values than those g/l, (n = 3096) (p < 0-001). )ne. These effects were not simply Figure 1 and table 4 show the age adjusted as this was comparable across all and multiple adjusted odds ratios for myocargroups for both sexes (data not dial infarction across all quartiles of plasma fibrinogen concentrations. The odds ratios standardised mean (SE) fibrino-were consistently higher for men than for for men were 2-51 (002) g/l, (n = women. The male odds ratios were statisticalag cases of myocardial infarction ly significant in all quartiles of plasma fibrino-(0-01) g/l, (n = 3367) among gen and showed a significant linear trend (p < 0001), with no significant non-linear residual effect. Among women, the age adjusted odds Men ratio was significant (p < 0.01) for only the re significant associations of plasma Another study noted a raised plasma fibrinon concentration with family history gen concentration in patients with intermitature heart disease and also with tent claudication and also the higher the peripheral vascular disease, coro-concentration the worse the disease.'0 -art disease, and hypertension.
We have shown that prevalent coronary who reported a medical history of heart disease (myocardial infarction or angior stroke each had higher plasma fib-na) is associated with increased plasma fibconcentrations than those with no rinogen concentrations, confirming previous n the case control analyses, the risk studies.6-8 After inclusion of several variables either myocardial infarction or angi-that were associated with plasma fibrinogen ised as plasma fibrinogen concentra-concentrations in our study,'3 the strength of mased: the effects were more striking association between plasma fibrinogen and en than among women. prevalent coronary heart disease was reduced, is much evidence that people with a especially for angina in women (fig 2) . disease from a family history of premature heart disease to a personal history of hypertension, stroke, diabetes, peripheral vascular, and coronary heart disease. We noted, however, that some of these associations were stronger among men. This may, in part, have been due to the higher prevalence of disease among men.34 Alternatively, there may be real biological differences between the sexes that might explain the results. A history of high blood pressure, stroke, diabetes, angina, and myocardial infarction based on self report has not been validated within this study. Any loss of specificity and sensitivity would, however, tend to dilute the difference in plasma fibrinogen concentration between the history and no history groups, rather than abolish them.
It is interesting that we confirmed a raised fibrinogen concentration in subjects with angina. This suggests that fibrinogen may have a role in the narrowing of vessels before the start of thrombosis. It may also be involved in the pathogenesis of hypertension, although its predictive value cannot be entirely accounted for by its correlations with blood pressure or other risk factors. We have previously reported weak correlations between plasma fibrinogen and systolic blood pressure on entry to this population (rank correlations of -0 1 in men and 0 13 in women)."3
Results from one of the largest epidemiological studies of plasma fibrinogen reported to date confirm the importance of plasma fibrinogen as an important cardiovascular risk factor. Follow up of the participants in the Scottish Heart Health Study, currently in progress, will enable us to estimate the relative contribution of plasma fibrinogen concentrations to incidence of cardiovascular disease in a population with very high levels of coronary heart disease.
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